The Board has granted service connection for papillary renal cell carcinoma due to herbicide agent exposure during the Veteran's service in Vietnam, resolving reasonable doubt in favor of the Veteran.
The deciding factor: The Board found that the evidence was at least in equipoise as to whether the Veteran's papillary renal cell carcinoma was caused by his exposure to Agent Orange during his tour in Vietnam.
- Claimed conditions
- papillary renal cell carcinoma
- How they argued it
- Direct service connection
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- November 25, 2019
- Citation
- 19188771
Veterans Law Judge
Decisions by this judge: 2,200 · Granted: 43% (granted or partly granted, in the vetted decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 19188771.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Dismissed
The appeal to reduce the disability rating for papillary renal cell carcinoma from 100% to noncompensable (0%) is dismissed because it does not confer appellate rights.
- Granted
The Board has determined that the Veteran's papillary renal cell carcinoma is related to exposure to burn pits during his service in Iraq, and therefore grants the claim for service connection on a direct causation basis.
- Granted
The Veteran's papillary renal cell carcinoma is granted service connection. For the entire appeal period, a 70 percent rating for PTSD is granted and he is granted entitlement to TDIU based on his service-connected disabilities.
- Remanded (sent back)
The Board remands the claims for further medical development to determine whether the Veteran's papillary renal cell carcinoma is active or in remission, and if there has been cessation of treatment.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.